Drug Trial Radar · NCT07456696
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Apr 2, 2026
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Transcend TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter an 8-week Follow-up Period.
Conditions
- Post Traumatic Stress Disorder
Interventions
TSND-201Drug
TSND-201 capsules, given orally, once a week for four consecutive weeks
PlaceboDrug
Placebo capsules, given orally, once a week for four consecutive weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total Severity ScoreTime frame: Up to 12 weeks
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
Mountain Clinical Trials LLC
Phoenix, Arizona · Recruiting
Del Sol Research
Tucson, Arizona · Recruiting
Preferred Research Partners
Little Rock, Arkansas · Recruiting
Sun Valley Research
Imperial, California · Recruiting
Kadima Neuropsychiatry
La Jolla, California · Recruiting
CalNeuro Research Group
Los Angeles, California · Recruiting
Catalina Research Institute
Montclair, California · Recruiting
Excell Research
Oceanside, California · Recruiting
ATP Clinical Research
Orange, California · Recruiting
Inland Psychiatric Medical Group
San Juan Capistrano, California · Recruiting
Starlight Clinical Research
Evergreen, Colorado · Recruiting
CNS Healthcare
Jacksonville, Florida · Recruiting
Segal Trials
Lauderhill, Florida · Recruiting
Accel Clinical Research
Maitland, Florida · Recruiting
CNS Healthcare
Orlando, Florida · Recruiting
TrialMed
Atlanta, Georgia · Recruiting
Uptown Research Institute
Chicago, Illinois · Recruiting
DelRicht - New Orleans
New Orleans, Louisiana · Recruiting
Headlands Research - Pharmasite
Pikesville, Maryland · Recruiting
Vitalix Clinical
Worcester, Massachusetts · Recruiting
Arch Clinical Trials
Creve Coeur, Missouri · Recruiting
Midwest Research Group
Saint Charles, Missouri · Recruiting
Center for Emotional Fitness/ Lumina Clinical Research Center
Cherry Hill, New Jersey · Recruiting
Global Medical Institutes
Princeton, New Jersey · Recruiting
Bio Behavioral Health
Toms River, New Jersey · Recruiting
Medical Research Network
New York, New York · Recruiting
Insight Clinical Trials
Independence, Ohio · Recruiting
Flourish Research
Plymouth Meeting, Pennsylvania · Recruiting
Suburban Research Associates
West Chester, Pennsylvania · Recruiting
CNS Memphis
Memphis, Tennessee · Recruiting
Austin Clinical Trial Partners
Austin, Texas · Recruiting
Haracec Clinical Research
El Paso, Texas · Recruiting
Elevate Clinical Research
Houston, Texas · Recruiting
Cedar Clinical Research
Draper, Utah · Recruiting
Inner Space Research
Orem, Utah · Recruiting
Seattle Neuropsychiatric Treatment Center (NTC)
Seattle, Washington · Recruiting
Wisconsin-Madison
Madison, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.